Organisms | Evidence |
---|---|
Sus scrofa (pig) | |
unidentified influenza virus | |
Saccharomyces cerevisiae (brewer's yeast) |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT1 | UDP-Gal |
|
R |
|
R | |
B3GALT5 | UDP-Gal |
|
R |
|
R |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
Pathway Name | Organism |
---|---|
Antimicrobial peptides | Drosophila melanogaster |
Antimicrobial peptides | Rattus norvegicus |
Antimicrobial peptides | Danio rerio |
Antimicrobial peptides | Xenopus tropicalis |
Antimicrobial peptides | Gallus gallus |
Antimicrobial peptides | Homo sapiens |
Antimicrobial peptides | Canis familiaris |
Antimicrobial peptides | Dictyostelium discoideum |
Antimicrobial peptides | Bos taurus |
Antimicrobial peptides | Mus musculus |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
35641520 | Cryo-EM structures of human A2ML1 elucidate the protease-inhibitory mechanism of the A2M family | Nielsen NS | 2022 May 31 |
|
35637289 | O-GlcNAcylation modulates liquid-liquid phase separation of SynGAP/PSD-95 | Lv P | 2022 May 30 |
|
35637422 | Structural insights into binding of therapeutic channel blockers in NMDA receptors | Chou T | 2022 May 30 |
|
35617431 | Potent monoclonal antibody–mediated neutralization of a divergent Hendra virus variant | Wang Z | 2022 May 26 |
|
35614056 | Author Correction: O-GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine | Kim K | 2022 May 25 |
|
35438546 | An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses | Liu L | 2022 May 25 |
|
35412328 | Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice | Hunt AC | 2022 May 25 |
|
35614127 | Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes | Wang C | 2022 May 25 |
|
35477497 | Correction to: Engineered probiotics | Ma J | 2022 May 24 |
|
35613585 | Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies | Enriquez AS | 2022 May 24 |
|
Title | Authors | Source | Publication Date | PubMed ID |
---|---|---|---|---|
Dynamic glycosylation of the transcription factor CREB: a potential role in gene regulation. |
|
J Am Chem Soc | 2003 Jun 4 | 12769553 |
Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. |
|
Biochim Biophys Acta | 1999 Oct 18 | 10572927 |
Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. |
|
J Biol Chem | 1999 Nov 5 | 10542233 |
An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. |
|
J Biol Chem | 1999 May 21 | 10329728 |
Vertebrate lens alpha-crystallins are modified by O-linked N-acetylglucosamine. |
|
J Biol Chem | 1992 Jan 5 | 1730617 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025